Parkman Healthcare Partners as of Dec. 31, 2020
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 83 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dex (DXCM) | 3.9 | $15M | 42k | 369.73 | |
| Horizon Therapeutics Pub L SHS | 3.3 | $13M | 176k | 73.15 | |
| Vericel (VCEL) | 3.2 | $12M | 401k | 30.88 | |
| Schrodinger (SDGR) | 3.2 | $12M | 156k | 79.18 | |
| Aclaris Therapeutics (ACRS) | 3.1 | $12M | 1.9M | 6.47 | |
| Natera (NTRA) | 3.1 | $12M | 121k | 99.52 | |
| Danaher Corporation (DHR) | 2.7 | $11M | 48k | 222.14 | |
| Iqvia Holdings (IQV) | 2.7 | $10M | 58k | 179.17 | |
| Humana (HUM) | 2.6 | $10M | 25k | 410.27 | |
| Charles River Laboratories (CRL) | 2.5 | $9.9M | 40k | 249.86 | |
| Arrowhead Pharmaceuticals (ARWR) | 2.5 | $9.8M | 127k | 76.73 | |
| Gw Pharmaceuticals Ads | 2.4 | $9.4M | 82k | 115.41 | |
| GenMark Diagnostics | 2.3 | $9.0M | 618k | 14.60 | |
| Catalent (CTLT) | 2.2 | $8.8M | 84k | 104.07 | |
| Peregrine Pharmaceuticals (CDMO) | 2.2 | $8.6M | 750k | 11.54 | |
| UnitedHealth (UNH) | 2.2 | $8.4M | 24k | 350.69 | |
| Insulet Corporation (PODD) | 2.0 | $7.8M | 31k | 255.63 | |
| Kodiak Sciences (KOD) | 1.9 | $7.3M | 50k | 146.92 | |
| Dicerna Pharmaceuticals | 1.9 | $7.3M | 332k | 22.03 | |
| Alphatec Hldgs Com New (ATEC) | 1.9 | $7.3M | 503k | 14.52 | |
| Turning Point Therapeutics I | 1.9 | $7.2M | 59k | 121.85 | |
| Icad Com New (ICAD) | 1.8 | $7.2M | 543k | 13.20 | |
| Acceleron Pharma | 1.7 | $6.7M | 53k | 127.93 | |
| Seaspine Holdings | 1.7 | $6.5M | 375k | 17.45 | |
| Arcus Biosciences Incorporated (RCUS) | 1.5 | $6.0M | 232k | 25.96 | |
| Sutro Biopharma (STRO) | 1.5 | $5.8M | 267k | 21.71 | |
| Immunic (IMUX) | 1.4 | $5.6M | 367k | 15.29 | |
| Itamar Med Sponsored Ads | 1.4 | $5.6M | 282k | 19.86 | |
| Xenon Pharmaceuticals (XENE) | 1.4 | $5.6M | 362k | 15.38 | |
| Bridgebio Pharma (BBIO) | 1.4 | $5.4M | 76k | 71.12 | |
| Nuance Communications | 1.3 | $5.1M | 116k | 44.09 | |
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $4.7M | 36k | 129.97 | |
| Edwards Lifesciences (EW) | 1.2 | $4.6M | 51k | 91.23 | |
| InfuSystem Holdings (INFU) | 1.2 | $4.5M | 242k | 18.78 | |
| Silk Road Medical Inc Common (SILK) | 1.1 | $4.3M | 68k | 62.97 | |
| Ionis Pharmaceuticals (IONS) | 1.1 | $4.3M | 75k | 56.54 | |
| Avantor (AVTR) | 1.1 | $4.2M | 151k | 28.15 | |
| Repro-Med Systems (KRMD) | 1.1 | $4.2M | 701k | 6.02 | |
| Axogen (AXGN) | 1.1 | $4.1M | 231k | 17.90 | |
| BioCryst Pharmaceuticals (BCRX) | 1.0 | $4.0M | 538k | 7.45 | |
| Kadmon Hldgs | 1.0 | $3.9M | 934k | 4.15 | |
| Novavax Com New (NVAX) | 1.0 | $3.8M | 35k | 111.51 | |
| IDEXX Laboratories (IDXX) | 1.0 | $3.8M | 7.6k | 499.93 | |
| Gossamer Bio (GOSS) | 0.9 | $3.4M | 351k | 9.67 | |
| Stereotaxis Com New (STXS) | 0.8 | $3.3M | 648k | 5.09 | |
| Mersana Therapeutics (MRSN) | 0.8 | $3.3M | 123k | 26.61 | |
| 1life Healthcare | 0.8 | $3.3M | 75k | 43.65 | |
| Health Catalyst (HCAT) | 0.8 | $3.3M | 75k | 43.53 | |
| Abbvie (ABBV) | 0.8 | $3.2M | 30k | 107.17 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.8 | $3.1M | 110k | 28.05 | |
| Eidos Therapeutics | 0.7 | $2.8M | 22k | 131.57 | |
| Immunovant (IMVT) | 0.7 | $2.8M | 61k | 46.18 | |
| Axsome Therapeutics (AXSM) | 0.6 | $2.5M | 31k | 81.47 | |
| Trillium Therapeutics Com New | 0.6 | $2.4M | 165k | 14.71 | |
| 89bio (ETNB) | 0.6 | $2.4M | 97k | 24.37 | |
| BioMarin Pharmaceutical (BMRN) | 0.6 | $2.2M | 25k | 87.68 | |
| Smiledirectclub Cl A Com (SDCCQ) | 0.5 | $2.1M | 176k | 11.94 | |
| Atreca Cl A Com (BCEL) | 0.5 | $2.0M | 126k | 16.15 | |
| Kala Pharmaceuticals | 0.5 | $1.8M | 272k | 6.78 | |
| Oncternal Therapeutics | 0.5 | $1.8M | 377k | 4.90 | |
| Avrobio Ord (AVRO) | 0.4 | $1.7M | 121k | 13.94 | |
| Surface Oncology | 0.4 | $1.6M | 176k | 9.24 | |
| Outset Med (OM) | 0.4 | $1.6M | 28k | 56.86 | |
| Curis Com New | 0.4 | $1.6M | 195k | 8.19 | |
| Castle Biosciences (CSTL) | 0.4 | $1.5M | 23k | 67.15 | |
| Molecular Templates | 0.4 | $1.5M | 160k | 9.39 | |
| Madrigal Pharmaceuticals (MDGL) | 0.4 | $1.4M | 13k | 111.21 | |
| Nephros (NEPH) | 0.4 | $1.4M | 167k | 8.58 | |
| Profound Med Corp Com New (PROF) | 0.4 | $1.4M | 69k | 20.57 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.3 | $1.3M | 75k | 17.67 | |
| Aurinia Pharmaceuticals (AUPH) | 0.3 | $1.2M | 90k | 13.83 | |
| Catalyst Biosciences Com New | 0.3 | $1.2M | 189k | 6.31 | |
| Forte Biosciences (FBRX) | 0.3 | $1.1M | 31k | 36.40 | |
| Altimmune Com New (ALT) | 0.3 | $1.1M | 100k | 11.28 | |
| Biolinerx Sponsored Ads (BLRX) | 0.3 | $1.1M | 428k | 2.52 | |
| Syndax Pharmaceuticals (SNDX) | 0.2 | $698k | 31k | 22.24 | |
| Fate Therapeutics (FATE) | 0.2 | $692k | 7.6k | 90.87 | |
| Edap Tms S A Sponsored Adr (EDAP) | 0.2 | $672k | 130k | 5.17 | |
| Concert Pharmaceuticals I equity | 0.2 | $636k | 50k | 12.65 | |
| Verastem | 0.1 | $536k | 251k | 2.13 | |
| Rapt Therapeutics (RAPT) | 0.1 | $497k | 25k | 19.74 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.1 | $371k | 111k | 3.36 | |
| Aerpio Pharmaceuticals | 0.1 | $259k | 264k | 0.98 |
